4.50
-0.2(-4.26%)
Currency In USD
| Previous Close | 4.7 |
| Open | 4.65 |
| Day High | 4.73 |
| Day Low | 4.5 |
| 52-Week High | 68.7 |
| 52-Week Low | 4.22 |
| Volume | 80,752 |
| Average Volume | 503,486 |
| Market Cap | 12.05M |
| PE | -0.19 |
| EPS | -24.28 |
| Moving Average 50 Days | 6.41 |
| Moving Average 200 Days | 14.47 |
| Change | -0.2 |
If you invested $1000 in Cellectar Biosciences, Inc. (CLRB) 10 years ago, it would be worth $0.05 as of August 20, 2025 at a share price of $4.5. Whereas If you bought $1000 worth of Cellectar Biosciences, Inc. (CLRB) shares 5 years ago, it would be worth $12.3 as of August 20, 2025 at a share price of $4.5.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Cellectar Biosciences to Report Second Quarter Financial Results and Host a Conference Call on Thursday, August 14, 2025
GlobeNewswire Inc.
Aug 07, 2025 12:05 PM GMT
FLORHAM PARK, N.J., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer, toda
Cellectar Biosciences Announces Closing of $6.9 Million Underwritten Public Offering, including Full Exercise of Over-Allotment Option
GlobeNewswire Inc.
Jul 02, 2025 8:15 PM GMT
FLORHAM PARK, N.J., July 02, 2025 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq: CLRB) (the “Company”), a late-stage clinical biopharmaceutical company focused on the discovery and development of drugs for the treatment of cancer, today a
Cellectar Biosciences Announces Pricing of $6 Million Underwritten Public Offering
GlobeNewswire Inc.
Jul 01, 2025 1:25 PM GMT
FLORHAM PARK, N.J., July 01, 2025 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq: CLRB) (the “Company”), a late-stage clinical biopharmaceutical company focused on the discovery and development of drugs for the treatment of cancer, today a